Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online February 15, 2007
Diabetes 56:1268-1276, 2007
DOI: 10.2337/db06-0658
© 2007 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
db06-0658v1
56/5/1268    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Herbach, N.
Right arrow Articles by Wanke, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Herbach, N.
Right arrow Articles by Wanke, R.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Dominant-Negative Effects of a Novel Mutated Ins2 Allele Causes Early-Onset Diabetes and Severe ß-Cell Loss in Munich Ins2C95S Mutant Mice

Nadja Herbach1, Birgit Rathkolb2, Elisabeth Kemter1, Lisa Pichl1, Matthias Klaften3, Martin Hrabé de Angelis3, Philippe A. Halban4, Eckhard Wolf2, Bernhard Aigner2, and Ruediger Wanke1

1 Institute of Veterinary Pathology, University of Munich, Munich, Germany
2 Institute of Molecular Animal Breeding/Gene Center, University of Munich, Munich, Germany
3 Institute of Experimental Genetics, GSF-National Research Center for Environment and Health, Neuherberg, Germany
4 Department of Genetic Medicine and Development, CMU, Geneva, Switzerland

Address correspondence and reprint requests to Nadja Herbach, Institute of Veterinary Pathology, Veterinaerstr. 13, 80539 Munich, Germany. E-mail: herbach{at}patho.vetmed.uni-muenchen.de

Abbreviations: ENU, N-ethyl-N-nitrosourea; HOMA, homeostasis model assessment; OGTT, oral glucose tolerance test; PP, pancreatic polypeptide

The novel diabetic mouse model Munich Ins2C95S was discovered within the Munich N-ethyl-N-nitrosourea mouse mutagenesis screen. These mice exhibit a T->A transversion in the insulin 2 (Ins2) gene at nucleotide position 1903 in exon 3, which leads to the amino acid exchange C95S and loss of the A6-A11 intrachain disulfide bond. From 1 month of age onwards, blood glucose levels of heterozygous Munich Ins2C95S mutant mice were significantly increased compared with controls. The fasted and postprandial serum insulin levels of the heterozygous mutants were indistinguishable from those of wild-type littermates. However, serum insulin levels after glucose challenge, pancreatic insulin content, and homeostasis model assessment (HOMA) ß-cell indices of heterozygous mutants were significantly lower than those of wild-type littermates. The initial blood glucose decrease during an insulin tolerance test was lower and HOMA insulin resistance indices were significantly higher in mutant mice, indicating the development of insulin resistance in mutant mice. The total islet volume, the volume density of ß-cells in the islets, and the total ß-cell volume of heterozygous male mutants was significantly reduced compared with wild-type mice. Electron microscopy of the ß-cells of male mutants showed virtually no secretory insulin granules, the endoplasmic reticulum was severely enlarged, and mitochondria appeared swollen. Thus, Munich Ins2C95S mutant mice are considered a valuable model to study the mechanisms of ß-cell dysfunction and death during the development of diabetes.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
E. L. Edghill, S. E. Flanagan, A.-M. Patch, C. Boustred, A. Parrish, B. Shields, M. H. Shepherd, K. Hussain, R. R. Kapoor, M. Malecki, et al.
Insulin Mutation Screening in 1,044 Patients With Diabetes: Mutations in the INS Gene Are a Common Cause of Neonatal Diabetes but a Rare Cause of Diabetes Diagnosed in Childhood or Adulthood
Diabetes, April 1, 2008; 57(4): 1034 - 1042.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Liu, I. Hodish, C. J. Rhodes, and P. Arvan
Proinsulin maturation, misfolding, and proteotoxicity
PNAS, October 2, 2007; 104(40): 15841 - 15846.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Stoy, E. L. Edghill, S. E. Flanagan, H. Ye, V. P. Paz, A. Pluzhnikov, J. E. Below, M. G. Hayes, N. J. Cox, G. M. Lipkind, et al.
Insulin gene mutations as a cause of permanent neonatal diabetes
PNAS, September 18, 2007; 104(38): 15040 - 15044.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2007 by the American Diabetes Association.